PCR & NGS Based Diagnostic Testing Market - Forecast Report 2027

PCR & NGS Based Diagnostic Testing Market - By Product (Consumables, Equipment, Labware), By End-use (Hospitals and Clinics, Diagnostic Centers, Ambulatory Settings) & Forecast, 2021-2027

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data validation

1.5&nbsp;&nbsp;&nbsp; Data Sources

1.5.1&nbsp;&nbsp;&nbsp; Secondary

1.5.1.1&nbsp;&nbsp;&nbsp; Paid Sources

1.5.1.2&nbsp;&nbsp;&nbsp; Unpaid Sources

1.5.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; PCR &amp; NGS based Diagnostic testing industry 3600 synopsis, 2016 &ndash; 2027

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Product trends

2.1.3&nbsp;&nbsp;&nbsp; End-use trends

2.1.4&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;PCR &amp; NGS based Diagnostic Testing Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2016 &ndash; 2027

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp; Rising importance of diagnostic tests in virus detection

3.3.1.2&nbsp;&nbsp;&nbsp; Growing usage of NGS technology by pharmaceutical and biopharmaceutical companies

3.3.1.3&nbsp;&nbsp;&nbsp; Increasing research and developmental (R&amp;D) activities in developed economies

3.3.1.4&nbsp;&nbsp;&nbsp; High risk of infection in geriatric population

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls and challenges

3.3.2.1&nbsp;&nbsp;&nbsp; High cost of diagnostic testing

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By product

3.4.2&nbsp;&nbsp;&nbsp; By end-use

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5.1&nbsp;&nbsp;&nbsp; Impact of COVID-19 on global PCR &amp; NGS based diagnostic testing market

3.5.2&nbsp;&nbsp;&nbsp; Impact of COVID-19 on industry value chain

3.5.2.1&nbsp;&nbsp;&nbsp; Research and development

3.5.2.2&nbsp;&nbsp;&nbsp; Manufacturing

3.5.2.3&nbsp;&nbsp;&nbsp; Marketing

3.5.2.4&nbsp;&nbsp;&nbsp; Supply

3.5.3&nbsp;&nbsp;&nbsp; Impact of COVID-19 on industry competition

3.5.3.1&nbsp;&nbsp;&nbsp; Strategy

3.5.3.2&nbsp;&nbsp;&nbsp; Product portfolio

3.5.3.3&nbsp;&nbsp;&nbsp; Business growth

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; Competitive landscape, 2020

3.7.1&nbsp;&nbsp;&nbsp; Company matrix analysis, 2020

3.7.2&nbsp;&nbsp;&nbsp; Manufacturing scenario

3.7.2.1&nbsp;&nbsp;&nbsp; List of equipment manufacturers in the U.S., Europe, and Asia

3.7.2.2&nbsp;&nbsp;&nbsp; List of consumable manufacturers in the U.S., Europe, and Asia

3.8&nbsp;&nbsp;&nbsp; Consumer dynamics: equipment purchase vs leasing

3.9&nbsp;&nbsp;&nbsp; Supply chain analysis

3.10&nbsp;&nbsp;&nbsp; PESTEL analysis

3.11&nbsp;&nbsp;&nbsp; Technology roadmap and future trends

Chapter 4&nbsp;&nbsp;&nbsp;PCR &amp; NGS based Diagnostic Testing Market, By Product

4.1&nbsp;&nbsp;&nbsp; Key segment trends

4.2&nbsp;&nbsp;&nbsp; Consumables

4.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027

4.3&nbsp;&nbsp;&nbsp; Equipment

4.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027

4.4&nbsp;&nbsp;&nbsp; Labware

4.4.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027

Chapter 5&nbsp;&nbsp;&nbsp;PCR &amp; NGS based Diagnostic Testing Market, By End-use

5.1&nbsp;&nbsp;&nbsp; Key segment trends

5.2&nbsp;&nbsp;&nbsp; Hospitals and clinics

5.2.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027

5.3&nbsp;&nbsp;&nbsp; Diagnostic centers

5.3.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027

5.4&nbsp;&nbsp;&nbsp; Ambulatory settings

5.4.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027

5.5&nbsp;&nbsp;&nbsp; Others

5.5.1&nbsp;&nbsp;&nbsp; Market size, by region, 2016 &ndash; 2027

Chapter 6&nbsp;&nbsp;&nbsp;PCR &amp; NGS based Diagnostic Testing Market, By Region

6.1&nbsp;&nbsp;&nbsp; Key regional trends

6.2&nbsp;&nbsp;&nbsp; North America

6.2.1&nbsp;&nbsp;&nbsp; Market size, by country, 2016 &ndash; 2027

6.2.2&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.2.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.2.4&nbsp;&nbsp;&nbsp; U.S.

6.2.4.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.2.4.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.2.5&nbsp;&nbsp;&nbsp; Canada

6.2.5.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.2.5.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.3&nbsp;&nbsp;&nbsp; Europe

6.3.1&nbsp;&nbsp;&nbsp; Market size, by country, 2016 &ndash; 2027

6.3.2&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.3.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.3.4&nbsp;&nbsp;&nbsp; UK

6.3.4.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.3.4.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.3.5&nbsp;&nbsp;&nbsp; France

6.3.5.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.3.5.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.3.6&nbsp;&nbsp;&nbsp; Germany

6.3.6.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.3.6.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.3.7&nbsp;&nbsp;&nbsp; Italy

6.3.7.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.3.7.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.3.8&nbsp;&nbsp;&nbsp; Spain

6.3.8.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.3.8.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.4&nbsp;&nbsp;&nbsp; Asia Pacific

6.4.1&nbsp;&nbsp;&nbsp; Market size, by country, 2016 &ndash; 2027

6.4.2&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.4.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.4.4&nbsp;&nbsp;&nbsp; India

6.4.4.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.4.4.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.4.5&nbsp;&nbsp;&nbsp; China

6.4.5.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.4.5.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.4.6&nbsp;&nbsp;&nbsp; Japan

6.4.6.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.4.6.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.4.7&nbsp;&nbsp;&nbsp; Australia

6.4.7.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.4.7.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.5&nbsp;&nbsp;&nbsp; Latin America

6.5.1&nbsp;&nbsp;&nbsp; Market size, by country, 2016 &ndash; 2027

6.5.2&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.5.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.5.4&nbsp;&nbsp;&nbsp; Brazil

6.5.4.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.5.4.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.5.5&nbsp;&nbsp;&nbsp; Mexico

6.5.5.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.5.5.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.6&nbsp;&nbsp;&nbsp; MEA

6.6.1&nbsp;&nbsp;&nbsp; Market size, by country, 2016 &ndash; 2027

6.6.2&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.6.3&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.6.4&nbsp;&nbsp;&nbsp; Saudi Arabia

6.6.4.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.6.4.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

6.6.5&nbsp;&nbsp;&nbsp; South Africa

6.6.5.1&nbsp;&nbsp;&nbsp; Market size, by product, 2016 &ndash; 2027

6.6.5.2&nbsp;&nbsp;&nbsp; Market size, by end-use, 2016 &ndash; 2027

Chapter 7&nbsp;&nbsp;&nbsp;Company Profiles

7.1&nbsp;&nbsp;&nbsp; Strategy dashboard, 2020

7.2&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc

7.2.1&nbsp;&nbsp;&nbsp; Business Overview

7.2.2&nbsp;&nbsp;&nbsp; Financial data

7.2.3&nbsp;&nbsp;&nbsp; Product landscape

7.2.4&nbsp;&nbsp;&nbsp; Strategic outlook

7.2.5&nbsp;&nbsp;&nbsp; SWOT analysis

7.3&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc

7.3.1&nbsp;&nbsp;&nbsp; Business overview

7.3.2&nbsp;&nbsp;&nbsp; Financial data

7.3.3&nbsp;&nbsp;&nbsp; Product landscape

7.3.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.4&nbsp;&nbsp;&nbsp; Eppendorf AG

7.4.1&nbsp;&nbsp;&nbsp; Business Overview

7.4.2&nbsp;&nbsp;&nbsp; Financial data

7.4.3&nbsp;&nbsp;&nbsp; Product Landscape

7.4.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.5&nbsp;&nbsp;&nbsp; Fluotics

7.5.1&nbsp;&nbsp;&nbsp; Business overview

7.5.2&nbsp;&nbsp;&nbsp; Financial data

7.5.3&nbsp;&nbsp;&nbsp; Product landscape

7.5.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.6&nbsp;&nbsp;&nbsp; Hamilton Company

7.6.1&nbsp;&nbsp;&nbsp; Business overview

7.6.2&nbsp;&nbsp;&nbsp; Financial data

7.6.3&nbsp;&nbsp;&nbsp; Product landscape

7.6.4&nbsp;&nbsp;&nbsp; Strategic outlook

7.6.5&nbsp;&nbsp;&nbsp; SWOT analysis

7.7&nbsp;&nbsp;&nbsp; Illumina, Inc

7.7.1&nbsp;&nbsp;&nbsp; Business Overview

7.7.2&nbsp;&nbsp;&nbsp; Financial data

7.7.3&nbsp;&nbsp;&nbsp; Product landscape

7.7.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.8&nbsp;&nbsp;&nbsp; Integra LifeScience Holdings Corporation

7.8.1&nbsp;&nbsp;&nbsp; Business overview

7.8.2&nbsp;&nbsp;&nbsp; Financial data

7.8.3&nbsp;&nbsp;&nbsp; Product landscape

7.8.4&nbsp;&nbsp;&nbsp; Strategic outlook

7.8.5&nbsp;&nbsp;&nbsp; SWOT analysis

7.9&nbsp;&nbsp;&nbsp; MGI Tech Co , Ltd

7.9.1&nbsp;&nbsp;&nbsp; Business overview

7.9.2&nbsp;&nbsp;&nbsp; Financial data

7.9.3&nbsp;&nbsp;&nbsp; Product landscape

7.9.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.10&nbsp;&nbsp;&nbsp; Mascon, Inc.

7.10.1&nbsp;&nbsp;&nbsp; Business Overview

7.10.2&nbsp;&nbsp;&nbsp; Financial data

7.10.3&nbsp;&nbsp;&nbsp; Product Landscape

7.10.4&nbsp;&nbsp;&nbsp; SWOT analysis

7.11&nbsp;&nbsp;&nbsp; Qiagen

7.11.1&nbsp;&nbsp;&nbsp; Business Overview

7.11.2&nbsp;&nbsp;&nbsp; Financial data

7.11.3&nbsp;&nbsp;&nbsp; Product Landscape

7.11.4&nbsp;&nbsp;&nbsp; Strategy outlook

7.11.5&nbsp;&nbsp;&nbsp; SWOT analysis

7.12&nbsp;&nbsp;&nbsp; Roche Diagnostics

7.12.1&nbsp;&nbsp;&nbsp; Business Overview

7.12.2&nbsp;&nbsp;&nbsp; Financial data

7.12.3&nbsp;&nbsp;&nbsp; Product Landscape

7.12.4&nbsp;&nbsp;&nbsp; Strategy outlook

7.12.5&nbsp;&nbsp;&nbsp; SWOT analysis

7.13&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

7.13.1&nbsp;&nbsp;&nbsp; Business Overview

7.13.2&nbsp;&nbsp;&nbsp; Financial data

7.13.3&nbsp;&nbsp;&nbsp; Product Landscape

7.13.4&nbsp;&nbsp;&nbsp; Strategy outlook

7.13.5&nbsp;&nbsp;&nbsp; SWOT analysis

7.14&nbsp;&nbsp;&nbsp; Thomas Scientific (The Carlyle Group)

7.14.1&nbsp;&nbsp;&nbsp; Business Overview

7.14.2&nbsp;&nbsp;&nbsp; Financial data

7.14.3&nbsp;&nbsp;&nbsp; Product Landscape

7.14.4&nbsp;&nbsp;&nbsp; Strategy outlook

7.14.5&nbsp;&nbsp;&nbsp; SWOT analysis

7.15&nbsp;&nbsp;&nbsp; VWR International (Avantor, Inc.)

7.15.1&nbsp;&nbsp;&nbsp; Business Overview

7.15.2&nbsp;&nbsp;&nbsp; Financial data

7.15.3&nbsp;&nbsp;&nbsp; Product Landscape

7.15.4&nbsp;&nbsp;&nbsp; Strategy outlook

7.15.5&nbsp;&nbsp;&nbsp; SWOT analysis 
&nbsp;

PCR & NGS Based Diagnostic Testing Market

Customize This Report

Industries

Information

Link

Global Headquarters